Yuki Toda

539 total citations
36 papers, 423 citations indexed

About

Yuki Toda is a scholar working on Molecular Biology, Immunology and Hematology. According to data from OpenAlex, Yuki Toda has authored 36 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 9 papers in Immunology and 7 papers in Hematology. Recurrent topics in Yuki Toda's work include Multiple Myeloma Research and Treatments (6 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers) and Extracellular vesicles in disease (4 papers). Yuki Toda is often cited by papers focused on Multiple Myeloma Research and Treatments (6 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers) and Extracellular vesicles in disease (4 papers). Yuki Toda collaborates with scholars based in Japan, United States and India. Yuki Toda's co-authors include Eishi Ashihara, Kazuyuki Takata, Yoshihisa Kitamura, Shigekuni Hosogi, Susumu Nakata, Shohei Kawanishi, Yoshitaka Yano, Kazuya Kobayashi, Kenichi Akaji and Yuko Nakagawa and has published in prestigious journals such as Biochemical and Biophysical Research Communications, International Journal of Molecular Sciences and Neuroscience.

In The Last Decade

Yuki Toda

33 papers receiving 419 citations

Peers

Yuki Toda
Nicolas Currier United States
A. Sengupta United States
Kevin Brady United Kingdom
Sun‐Ryung Lee South Korea
Zhishuo Ou United States
Chun Ho Song South Korea
F. Horn Germany
Yuki Toda
Citations per year, relative to Yuki Toda Yuki Toda (= 1×) peers Jingshu Tang

Countries citing papers authored by Yuki Toda

Since Specialization
Citations

This map shows the geographic impact of Yuki Toda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuki Toda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuki Toda more than expected).

Fields of papers citing papers by Yuki Toda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuki Toda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuki Toda. The network helps show where Yuki Toda may publish in the future.

Co-authorship network of co-authors of Yuki Toda

This figure shows the co-authorship network connecting the top 25 collaborators of Yuki Toda. A scholar is included among the top collaborators of Yuki Toda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuki Toda. Yuki Toda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Toda, Yuki, et al.. (2025). Akt Regulates Extracellular Vesicle Secretion in Hypoxia-adapted Multiple Myeloma RPMI8226 Cells. Anticancer Research. 45(4). 1355–1366.
2.
Hosogi, Shigekuni, Seikou Nakamura, Nobuyo Tamiya, et al.. (2025). Ginsenoside Rd Activates Ciliary Beat Frequency <i>via</i> Estrogen Receptor <i>β</i> and P2X7 Receptor. Biological and Pharmaceutical Bulletin. 48(5). 657–671.
3.
Yamada, Tadaaki, et al.. (2024). POLD1 Is Required for Cell Cycle Progression by Overcoming DNA Damage in Malignant Pleural Mesothelioma. Cancer Genomics & Proteomics. 21(2). 158–165. 3 indexed citations
4.
Toda, Yuki, Sang‐Bing Ong, Toshiyuki Yano, et al.. (2024). Downregulation of Mitochondrial Fusion Protein Expression Affords Protection from Canonical Necroptosis in H9c2 Cardiomyoblasts. International Journal of Molecular Sciences. 25(5). 2905–2905. 8 indexed citations
5.
Shimizu, Masaki, Wataru Ohwada, Toshiyuki Yano, et al.. (2024). Contribution of MLKL to the development of doxorubicin-induced cardiomyopathy and its amelioration by rapamycin. Journal of Pharmacological Sciences. 156(1). 9–18. 3 indexed citations
6.
Kouzu, Hidemichi, Tatsuya Sato, Atsushi Kuno, et al.. (2023). Downregulation of extramitochondrial BCKDH and its uncoupling from AMP deaminase in type 2 diabetic OLETF rat hearts. Physiological Reports. 11(4). e15608–e15608. 11 indexed citations
7.
Sato, Tatsuya, Yuki Toda, Masaki Shimizu, et al.. (2023). Adenosine monophosphate deaminase in the endoplasmic reticulum–mitochondria interface promotes mitochondrial Ca2+ overload in type 2 diabetes rat hearts. Journal of Diabetes Investigation. 14(4). 560–569. 7 indexed citations
8.
Toda, Yuki, et al.. (2023). Targeting acidic pre-metastatic niche in lungs by pH low insertion peptide and its utility for anti-metastatic therapy. Frontiers in Oncology. 13. 1258442–1258442. 5 indexed citations
9.
Sugiyama, Yuki, Seikou Nakamura, Yuichi Tokuda, et al.. (2022). 7,8-Dihydroxy-3-(4′-hydroxyphenyl)coumarin inhibits invasion and migration of osteosarcoma cells. Biochemical and Biophysical Research Communications. 638. 200–209. 4 indexed citations
10.
Yano, Toshiyuki, Atsushi Kuno, Masaya Tanno, et al.. (2022). Nuclear translocation of MLKL enhances necroptosis by a RIP1/RIP3-independent mechanism in H9c2 cardiomyoblasts. Journal of Pharmacological Sciences. 151(2). 134–143. 8 indexed citations
11.
Yoshioka, Makoto, Kuniaki Tanaka, Shyh‐Ming Yang, et al.. (2021). CN470 is a BET/CBP/p300 multi-bromodomain inhibitor and has an anti-tumor activity against MLL-rearranged acute lymphoblastic leukemia. Biochemical and Biophysical Research Communications. 590. 49–54. 11 indexed citations
12.
Sano, Y., et al.. (2021). Expression level of BTN3A1 on the surface of CD14+ monocytes is a potential predictor of γδ T cell expansion efficiency. Biochemical and Biophysical Research Communications. 588. 47–54. 4 indexed citations
13.
Nishimura, Kaneyasu, Shohei Kawanishi, Yuki Toda, et al.. (2020). Mouse Bone Marrow-derived Microglia-like Cells Secrete Transforming Growth Factor-β1 and Promote Microglial Aβ Phagocytosis and Reduction of Brain Aβ. Neuroscience. 438. 217–228. 20 indexed citations
14.
Hattori, Yasunao, et al.. (2020). A novel dipeptide type inhibitor of the Wnt/β-catenin pathway suppresses proliferation of acute myelogenous leukemia cells. Biochemical and Biophysical Research Communications. 535. 73–79. 10 indexed citations
15.
Toda, Yuki, Kanae Yamada, Susumu Nakata, et al.. (2019). DJ-1 Contributes to Self-renewal of Stem Cells in the U87-MG Glioblastoma Cell Line. Anticancer Research. 39(11). 5983–5990. 8 indexed citations
16.
Yoshizawa, Masato, Seikou Nakamura, Yuki Sugiyama, et al.. (2019). 6-Hydroxythiobinupharidine Inhibits Migration of LM8 Osteosarcoma Cells by Decreasing Expression of LIM Domain Kinase 1. Anticancer Research. 39(12). 6507–6513. 10 indexed citations
17.
Yoshioka, Makoto, Jay Chauhan, Susumu Nakata, et al.. (2017). CG13250, a novel bromodomain inhibitor, suppresses proliferation of multiple myeloma cells in an orthotopic mouse model. Biochemical and Biophysical Research Communications. 484(2). 262–268. 17 indexed citations
18.
Fukuda, Hiroki, Seikou Nakamura, Tetsuya Takada, et al.. (2016). Daphnetin inhibits invasion and migration of LM8 murine osteosarcoma cells by decreasing RhoA and Cdc42 expression. Biochemical and Biophysical Research Communications. 471(1). 63–67. 31 indexed citations
19.
Toda, Yuki, Kazuyuki Takata, Yuko Nakagawa, et al.. (2014). Effective internalization of U251-MG-secreted exosomes into cancer cells and characterization of their lipid components. Biochemical and Biophysical Research Communications. 456(3). 768–773. 56 indexed citations
20.
Yoshiya, Taku, et al.. (2011). Click Peptide Concept: O‐Acyl Isopeptide of Islet Amyloid Polypeptide as a Nonaggregative Precursor Molecule. ChemBioChem. 12(8). 1216–1222. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026